These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2341303)

  • 1. On the peptide model of allorecognition: cytotoxic T lymphocytes recognize an alloantigen encoded by two HLA-linked genes.
    Schendel DJ
    Hum Immunol; 1990 Mar; 27(3):229-39. PubMed ID: 2341303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A naturally processed peptide presented by HLA-A*0201 is expressed at low abundance and recognized by an alloreactive CD8+ cytotoxic T cell with apparent high affinity.
    Wang W; Gulden PH; Pierce RA; Shabanowitz J; Man ST; Hunt DF; Engelhard VH
    J Immunol; 1997 Jun; 158(12):5797-804. PubMed ID: 9190931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-A2 peptides can regulate cytolysis by human allogeneic T lymphocytes.
    Clayberger C; Parham P; Rothbard J; Ludwig DS; Schoolnik GK; Krensky AM
    Nature; 1987 Dec 24-31; 330(6150):763-5. PubMed ID: 3501071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of xeno-(HLA, SLA) major histocompatibility complex antigens by mouse cytotoxic T cells is not H-2 restricted: a study with transgenic mice.
    Kievits F; Wijffels J; Lokhorst W; Ivanyi P
    Proc Natl Acad Sci U S A; 1989 Jan; 86(2):617-20. PubMed ID: 2783490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic T lymphocytes show HLA-C-restricted recognition of EBV-bearing cells and allorecognition of HLA class I molecules presenting self-peptides.
    Schendel DJ; Reinhardt C; Nelson PJ; Maget B; Pullen L; Bornkamm GW; Steinle A
    J Immunol; 1992 Oct; 149(7):2406-14. PubMed ID: 1326579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes.
    Romagnani C; Pietra G; Falco M; Mazzarino P; Moretta L; Mingari MC
    Hum Immunol; 2004 May; 65(5):437-45. PubMed ID: 15172443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of cytotoxic T cell lines to detect the segregation of a human minor alloantigen within families.
    Zier KS; Elkins WL; Pierson GR; Leo MM
    Hum Immunol; 1983 Jul; 7(3):117-29. PubMed ID: 6192117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-MHC-restricted peptides recognized by an alloreactive T lymphocyte clone.
    Udaka K; Wiesmüller KH; Kienle S; Jung G; Walden P
    J Immunol; 1996 Jul; 157(2):670-8. PubMed ID: 8752916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-restricted primary human histocompatibility leukocyte antigen (HLA)-specific cytotoxic T lymphocytes.
    Breur-Vriesendorp BS; Ivanyi P
    Int Immunol; 1993 Jan; 5(1):103-7. PubMed ID: 8443120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide-induced changes in class I heavy chains alter allorecognition.
    Bluestone JA; Kaliyaperumal A; Jameson S; Miller S; Dick R
    J Immunol; 1993 Oct; 151(8):3943-53. PubMed ID: 8409378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of peptide involvement in T cell allorecognition using recombinant HLA class I multimers.
    Whitelegg AM; Oosten LE; Jordan S; Kester M; van Halteren AG; Madrigal JA; Goulmy E; Barber LD
    J Immunol; 2005 Aug; 175(3):1706-14. PubMed ID: 16034111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allorecognition of purified major histocompatibility complex glycoproteins by cytotoxic T lymphocytes.
    Elliott TJ; Eisen HN
    Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2728-32. PubMed ID: 2451830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Existence of MHC class I-restricted alloreactive CD4+ T cells reacting with peptide transporter-deficient cells.
    Kobayashi H; Kimura S; Aoki N; Sato K; Celis E; Katagiri M
    Immunogenetics; 2001 Oct; 53(8):626-33. PubMed ID: 11797095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition of breast cancer-associated peptides by tumor-reactive, HLA-class I restricted allogeneic cytotoxic T lymphocytes.
    Nguyen T; Naziruddin B; Dintzis S; Doherty GM; Mohanakumar T
    Int J Cancer; 1999 May; 81(4):607-15. PubMed ID: 10225452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloreactive cytotoxic T lymphocytes focus on specific major histocompatibility complex-bound peptides.
    Smith KD; Huczko E; Engelhard VH; Li YY; Lutz CT
    Transplantation; 1997 Jul; 64(2):351-9. PubMed ID: 9256200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mimicry by major histocompatibility complex molecules and peptides accounts for some alloresponses.
    Lechler RI; Heaton T; Barber L; Bal V; Batchelor JR; Lombardi G
    Immunol Lett; 1992 Sep; 34(1):63-9. PubMed ID: 1478706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide-mediated modulation of T-cell allorecognition.
    Eckels DD; Gorski J; Rothbard J; Lamb JR
    Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8191-5. PubMed ID: 2973061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creation of H-2 class I epitopes using synthetic peptides: recognition by alloreactive cytotoxic T lymphocytes.
    Olson CA; Williams LC; McLaughlin-Taylor E; McMillan M
    Proc Natl Acad Sci U S A; 1989 Feb; 86(3):1031-5. PubMed ID: 2783781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide-dependent recognition of H-2Kb by alloreactive cytotoxic T lymphocytes.
    Heath WR; Hurd ME; Carbone FR; Sherman LA
    Nature; 1989 Oct; 341(6244):749-52. PubMed ID: 2477713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants on major histocompatibility complex class I molecules recognized by cytotoxic T lymphocytes.
    Forman J
    Adv Immunol; 1987; 41():135-79. PubMed ID: 2446478
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.